Duration of Ivabradine Treatment
Appropriate Duration Based on Indication
- The American College of Cardiology recommends ivabradine as a reasonable option for ongoing management of patients with symptomatic inappropriate sinus tachycardia (IST) (Class IIa recommendation, Level of Evidence B-R) 1, 2, 3
- Ivabradine provides persistent clinical benefit in some patients with IST even after discontinuing the drug 2
Dosing and Administration Considerations
- Initial dosing of ivabradine typically starts at 5 mg twice daily, according to the American College of Cardiology 4
- Ivabradine can be titrated up to 7.5 mg twice daily based on heart rate response and symptom control, as recommended by the American College of Cardiology 2, 4
Safety Considerations for Long-Term Use
- Phosphenes (visual brightness phenomena) occur in approximately 3-15% of patients taking ivabradine, but are usually transient, as reported by the American College of Cardiology 2
Monitoring During Long-Term Treatment
- Regular assessment of heart rate response is recommended for patients taking ivabradine, according to the American College of Cardiology 4
- Ivabradine should be avoided in patients with severe hepatic impairment, as recommended by the American College of Cardiology 4
- Ivabradine should be avoided in patients with blood pressure <90/50 mm Hg, as recommended by the American College of Cardiology 4
- Ivabradine should be avoided in patients with decompensated heart failure, as recommended by the American College of Cardiology 4